Skip to main content
. 2017 Jul 25;12(7):e0181734. doi: 10.1371/journal.pone.0181734

Fig 6. DENV-DIII tetravalent vaccine formulation elicits DENV-specific neutralising antibodies.

Fig 6

A) Neutralisation and ADE of all four DENV serotypes, ZIKV, WNV and YFV, with pooled sera from mice vaccinated with the Tetra-DIII formulation (in all cases, for each virus-sera combination n = 3). B) FRNT50, as determined in (A), * indicates FRNT50 titres below detection limit of the assay (≥25).